載入...
AT-20 SINGLE INSTITUTION RETROSPECTIVE REVIEW OF PERFORMANCE STATUS AND CORTICOSTEROID USE IN NEWLY DIAGNOSED GLIOBLASTOMA (GBM) PATIENTS (PTS) TREATED ON BEVACIZUMAB (BEV)
BACKGROUND: Two multicenter phase III trials, RTOG0825 and AVAglio, evaluated the addition of BEV to radiation and temozolomide in newly diagnosed GBM and demonstrated a lack of statistically significant increased survival and discordant health-related quality of life results. We performed a retrosp...
Na minha lista:
Main Authors: | , , , , , , , , , , |
---|---|
格式: | Artigo |
語言: | Inglês |
出版: |
Oxford University Press
2014
|
主題: | |
在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4217798/ https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/nou237.20 |
標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|